4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-112179
Chief Executive Officer sold 2,782 shares at $5.20 ($14,452)
From the SEC's structured data for this filing
Trades in this filing
Rawcliffe Adrian · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Sale : show line 1 in the form | −2,782 | $5.20 | $14,452 | 3,070 | D |
| Open-market sales · 2,782 sh · avg $5.20 · $14,452 | ||||||
Loading xslF345X03/tm2126797-1_4seq1.xml…